← Scroll for more →
Erasca, Inc. (ERAS)
Pharmaceutical Preparations
Latest Price
$14.98
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
1.16
P/B Ratio
12.87
Institutional Ownership
90.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 24.98M | $457.0M | 7.99% | +300.0K | 2026-06-30 |
| T. Rowe Price Investment Management, Inc. | 21.19M | $388.0M | 6.78% | -73.8K | 2026-06-30 |
| BlackRock, Inc. | 21.15M | $387.0M | 6.77% | +1.00M | 2026-06-30 |
| Rtw Investments, LP | 17.95M | $328.0M | 5.74% | +1.79M | 2026-06-30 |
| Venrock Adviser, LLC | 17.89M | $327.0M | 5.72% | +1.51M | 2026-06-30 |
| State Street Corp | 12.18M | $223.0M | 3.90% | +2.88M | 2026-06-30 |
| Logos Global Management LP | 12.15M | $222.0M | 3.89% | +1.00M | 2026-06-30 |
| Vanguard Capital Management LLC | 11.40M | $208.0M | 3.65% | +152.5K | 2026-06-30 |
| Siren, L.L.C. | 11.40M | $208.0M | 3.65% | +153.5K | 2026-06-30 |
| Paradigm Biocapital Advisors LP | 9.55M | $174.0M | 3.06% | -842.7K | 2026-06-30 |